Skip to main content

Didactics

Academy of Teaching ScholarsThe fellowship program involves a series of didactic classes designed to provide basic skills in clinical design, pharmacokinetics and pharmacogenetics, biomarker assessment and development, as well as ethical issues in clinical research. Didactic courses take place within a rich academic research environment that involves the study of therapeutics in humans of all ages and ethnicities.

Friday Didactics Schedules

  • 2022

    January 21, 2022
    Univariate Continuous Statistical Data Analysis
    Forrest Williamson, PhD

    January 28, 2022
    Univariate Categorical Statistical Data Analysis
    Forrest Williamson, PhD

    February 4, 2022
    Statistical Tests and Model Building
    Forrest Williamson, PhD
    Paul H Berg, MS

    February 11, 2022
    Human Studies 1 (Design)
    Paul H Berg, MS

    February 25, 2022
    Human Studies 2 (Analysis/Interpretations)
    Forrest Williamson, PhD
    Paul H Berg, MS

    March 4, 2022
    Statistical Methods Useful in Clinical Pharmacology
    Paul H Berg, MS

  • 2021

    April 16, 2021
    Special Populations - Pregnancy
    Sara K. Quinney, PhD

    April 23, 2021
    Special Populations - Geriatric
    J. Thomas Callaghan, MD, PhD

    April 30, 2021
    Special Populations - Hepatic / Renal
    Michael T. Eadon, MD

    August 17, 2021
    Drug Measurement 1 - small molecule
    Andi Masters, MS

    September 3, 2021
    Drug Measurement 2 - macromolecular drugs
    Ronald Bowsher, PhD

    September 10, 2021
    Ch 1, 2 Therapeutic Relevance; Fundamental Concepts and Terminology;
    Appendix A Assessment of AUC
    Rich Bergstrom, PhD/Brian Overholser, PharmD

    September 17, 2021
    Ch 3 Kinetics Following and Intravenous Bolus Dose
    Appendix H Mean Residence Time
    Kevin Sowinski, PharmD

    September 24, 2021
    Ch 4, 19 Membranes and Distribution; Distribution Kinetics
    Appendix B Ionizabion an pH Partition Hypothesis; Appendix C
    Distribution of Drugs Extensively Bound to Plasma Proteins
    Sara Quinney, PhD

    October 1, 2021
    CH 5 Elimination; Appendix D Plasma-to-Blood Concentration Ratio;
    Appendix E Well-Stirred Model of Hepatic Clearance
    Brian Overholser, PharmD

    October 8, 2021
    CH 6, 7 Kinetics Following an Extravascular Dose; Absorption;
    Appendix F Absorption Kinetics; Appendix G Wagner-Nelson
    Kevin Sowinski, PharmD

    October 15, 2021
    CH 10 Constant-Rate Input
    Robert Stratford, PhD

    October 22, 2021
    CH 8, 9 Response Following a Single Dose; Therapeutic Window
    Brian Overholser, PharmD

    October 29, 2021
    CH 11, 18 Multiple Dose Regimens; Initiating and Managing
    Rich Bergstrom, PhD

    November 5, 2021
    CH 17, 20 Metabolite and Drug Response; Drug Interaction
    Robert Stratford, PhD

    November 12, 2021
    CH 12, 13 Variability; Genetics; Age, Weight, Gender, Disease
    Sara Quinney, PhD

    November 19, 2021
    CH 14, 15 Variability; Genetics; Age, Weight, Gender, Disease
    Sara Quinney, PhD

    November 26, 2021
    NO CLASS - THANKSGIVING BREAK

    December 3, 2021
    CH 16, Nonlinearities
    Sara Quinney, PhD

    December 10, 2021
    CH 21, 22 Protein Drugs; Predictions of Human PK from
    Rich Bergstrom,PhD

    December 17, 2021
    TAKE HOME FINAL EXAM

  • 2020

    January 10, 2020
    Statistical Analysis 1: Continuous Data
    Forrest Williamson, PhD

    January 17, 2020
    Statistacal Analysis 2 Categorical Data
    Forrest Williamson, PhD

    January 24, 2020
    Statistical Tests and Model Building
    Fanni Natanegara, PhD

    January 30, 2020
    Human Studies 1 (Design)
    Paul H. Berg, MS

    February 7, 2020
    Human Studies 2 (Analysis/Interpretations)
    Fanni Natanegara, PhD

    February 14, 2020
    Statistical Methods for Clinical Pharmacology
    Paul H. Berg, MS

    August 14, 2020
    Pharmacogenetics: General Concepts
    Todd Skaar, PhD

    August 21, 2020
    Clinical Relevance of CYP2C9 and CYP2C19 Genetic Polymorphism
    Zeruesenay Desta, PhD

    August 28, 2020
    Genotyping and Sequencing I
    Todd Skaar, PhD

    September 4, 2020
    Clinical Relevance of CYP2Cs Genetic Polymorphism
    Zeruesenay Desta, PhD

    September 11, 2020
    Genotyping and Sequencing II
    Todd Skaar, PhD

    September 18, 2020
    Pharmacogenetics of Phase II Metabolism: Glucuronidation
    Zeruesenay Desta, PhD

    September 25, 2020
    Pharmacogenetics of Phase II Metabolism: N-acetylation and Thiopurine Methyltransferase
    Zeruesenay Desta, PhD

    October 2, 2020
    Pharmacogenetics of CYP2D6
    Todd Skaar, PhD

    October 9, 2020
    Pharmacogenomics of CYP3A
    Todd Skaar, PhD

    October 16, 2020
    Phenoconversions
    Tom Callaghan, MD, PhD

    October 23, 2020
    No Didactics

    October 30, 2020
    No Didactics

    November 6, 2020
    Opioid Pharmacodynamics
    Tom Callaghan, MD, PhD

    November 13, 2020
    QT Prolongation
    Brian Overholser, PharmD, FDCP

    November 20, 2020
    Pharmacogenomics of Drug Transporters
    Michael Eadon, MD

    December 4, 2020
    Pharmacogenomics of Hypertension Therapies
    Michael Eadon, MD

    December 11, 2020
    Clinical Pharmacogenomics Testing
    Victoria Pratt, PhD, FACMG